Literature DB >> 6722556

In defence of optical density ratios in 2-deoxyglucose autoradiography.

I J Mitchell, A R Crossman.   

Abstract

The use of optical density ratios to describe changes in [14C]2-deoxyglucose uptake in neuroanatomical mapping experiments has recently been criticized. It has been argued that a fixed ratio of tissue isotope concentration does not yield a constant optical density ratio but is dependent on the exposure time and the absolute amounts of isotope used. Here it is demonstrated that such variations in optical density ratios are due to an artifact in calculating the optical density ratio, which can easily be corrected provided that the film is not approaching saturation and not due to the non-linearity of an exposure-density curve as has previously been suggested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6722556     DOI: 10.1016/0006-8993(84)91168-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Short and long-term changes in cerebral [14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity.

Authors:  K K Gnanalingham; N A Milkowski; L A Smith; A J Hunter; P Jenner; C D Marsden
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study.

Authors:  J A Kearney; K A Frey; R L Albin
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

3.  In vivo tracer studies of glucose metabolism, cerebral blood flow, and protein synthesis in naloxone precipitated morphine withdrawal.

Authors:  W A Geary; G F Wooten
Journal:  Neurochem Res       Date:  1987-07       Impact factor: 3.996

4.  A lesioning and 2-deoxyglucose study of the hyperactivity produced by an intra-accumbens dopamine agonist.

Authors:  S Patel; P Slater; A R Crossman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.